Stay updated on BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial
Sign up to get notified when there's something new on the BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial page.

Latest updates to the BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial page
- Check3 days agoChange DetectedThe study record remains inaccessible, displaying a 403 Forbidden error rather than trial details.SummaryDifference0.2%

- Check10 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record and removing the usual trial content from view.SummaryDifference17%

- Check31 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing Revision: v3.6.6. This reflects a site version update rather than changes to the trial details.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision information updated from v3.6.5 to v3.6.6, indicating a new version of the page. This change is metadata and does not modify the study details or participant information on the page.SummaryDifference0.1%

- Check52 days agoChange DetectedA 2014 U.S. NIH Grant/Contract was added to the study's funding/identifiers information, expanding the funding information for the trial.SummaryDifference0.1%

Stay in the know with updates to BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial page.